Nexera Medical
Product Claims: Canada Region Canada European Union European Union


The Next "ERA" in Germ Killing Protection for Health and Safety
 news
Nexera Medical's SpectraShield™ Plus FFP3 receives EN 149 approval as a FFP3 (French Version) respirator mask from INSPEC International Ltd., a European Union certified testing facility...

February 12, 2009 - Nexera Medical's SpectraShield™ Plus FFP3 receives EN 149: 2001 approval as a FFP3 (French Version) respirator mask from INSPEC International Ltd., a European Union certified testing facility located in Greater Manchester, United Kingdom. The tests were performed on the SpectraShield™ Plus FFP3 in simulation of the practical use of the apparatus under the conditions prevailing in the area of the laboratory. The testing method is the widely accepted method for measuring filtration performance which is known as the paraffin oil method. The tests resulted in a 99.7% or greater filtration efficiency for the SpectraShield™ Plus FFP3. A standard FFP3 European Union version requires 99% filtration efficiency, while the French version requires 99.7% filtration efficiency.

"Receiving this FFP3 French filtration designation continues our long term objective of developing the world's leading antimicrobial respirator mask for extended use which is designed to protect people in a widespread health crisis", according to Paul Sallarulo, President and Chief Executive Officer. Furthermore, he says; "We have met the challenges associated with creating an effective antimicrobial respirator mask by separately establishing the effective functionality of each aspect of the mask, including the antimicrobial aspects and the filtration aspects".

The antimicrobial aspects are recognized by the test results received from the Health Protection Agency against bacteria on November 8, 2008, and from RetroScreen Virology Ltd. against viruses on January 22, 2009, and this FFP3 approval recognizes the filtration aspects".

SpectraShield™ Plus FFP3 is manufactured using a patented technology; antimicrobial fibers used in the mask incorporate non-toxic silver-copper ionic agents proven safe for extended contact with individuals. Due to SpectraShield™ Plus FFP3's antimicrobial properties, the SpectraShield™ Plus FFP3 continuously self-sanitizes itself for extended use.

About Nexera Medical, Inc. Nexera Medical Inc. is engaged in the development, manufacturing and distribution of antimicrobial respirator and surgical masks, as well as other antimicrobial textile based medical products such as medical slings, surgical site aprons and hospital linen products worldwide. The company's mission is to create high-quality, cutting-edge health related medical products designed to safeguard and enhance the quality of human life. All of Nexera's products are designed to provide maximum protection against microorganisms such as bacteria, virus and fungus using Fosshield® patented technology. Nexera partners with governments and leaders in the health care industry in the fight against viral pandemic and other healthcare crises. For more information, visit www.nexeramed.com.

SpectraShield™ Plus FFP3 is a registered trademark of Nexera Medical, Inc.

Newsroom

"Nexera believes that the SpectraShield™ 9900 and SpectraShield™ Plus FFP3 antimicrobial respirator masks are the first antibacterial / antiviral respirator masks of its kind."

Copyright © 2018 Nexera Medical. All rights reserved.